Cabaletta Bio, Inc.
Cabaletta Bio, Inc. (CABA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CABA · as of Jun 8, 2026
Key Statistics
Explore Cabaletta Bio, Inc. Data
caba stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 83.3%
The CABA analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $16.33, representing +410.31% upside from the current price of $3.20.
Competitors & Peers
caba competitorsCABA
ALLO
AVIR
CAPR
EDIT
HUMAStock Performance
Full HistoryAbout Cabaletta Bio, Inc.
Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat …
what is cabaletta bio, inc. · caba stock overview · cabaletta bio, inc. company profile · who is cabaletta bio, inc. ceo · caba NASDAQ · cabaletta bio, inc. headquarters · cabaletta bio, inc. business segments
About Stock Overview & Key Data
Cabaletta Bio, Inc. (CABA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 25, 2019. As of the latest trading session, CABA stock price is $3.20, with a market capitalization of $521.8M. The stock has returned +34.17% over the past 12 months and +45.20% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Cabaletta Bio, Inc. stock is Buy, with an average 12-month price target of $16.33. In fiscal year 2025, Cabaletta Bio, Inc. reported revenue of — and net income of -$167.9M. For detailed data — including Cabaletta Bio, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cabaletta Bio, Inc. (CABA) stock price is $3.20. The stock is traded on NASDAQ under the ticker symbol CABA. The 52-week range is $1.26 – $4.23.